KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Cvs Health (CVS) over the last 13 years, with Q4 2025 value amounting to $998.0 million.

  • Cvs Health's Gains from Investment Securities rose 26423.36% to $998.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 2718.73%. This contributed to the annual value of $2.2 billion for FY2025, which is 2718.73% up from last year.
  • As of Q4 2025, Cvs Health's Gains from Investment Securities stood at $998.0 million, which was up 26423.36% from $305.0 million recorded in Q3 2025.
  • Cvs Health's Gains from Investment Securities' 5-year high stood at $1.8 billion during Q2 2022, with a 5-year trough of $44.0 million in Q1 2021.
  • Over the past 5 years, Cvs Health's median Gains from Investment Securities value was $761.5 million (recorded in 2021), while the average stood at $735.2 million.
  • In the last 5 years, Cvs Health's Gains from Investment Securities soared by 81393.94% in 2021 and then crashed by 6982.38% in 2024.
  • Over the past 5 years, Cvs Health's Gains from Investment Securities (Quarter) stood at $798.0 million in 2021, then soared by 31.08% to $1.0 billion in 2022, then decreased by 13.19% to $908.0 million in 2023, then crashed by 69.82% to $274.0 million in 2024, then surged by 264.23% to $998.0 million in 2025.
  • Its Gains from Investment Securities was $998.0 million in Q4 2025, compared to $305.0 million in Q3 2025 and $725.0 million in Q2 2025.